Seagle H, Akerele A, DeCorte J, Hellwege J, Breeyear J, Kim J
medRxiv. 2025; .
PMID: 40034783
PMC: 11875238.
DOI: 10.1101/2025.02.18.25321035.
Kawazoe Y, Tsuchiya M, Shimamoto K, Seki T, Shinohara E, Yada S
Sci Rep. 2025; 15(1):6678.
PMID: 39994365
PMC: 11850854.
DOI: 10.1038/s41598-025-91187-6.
Niu X, Zhao W, Zhou X, Luo F, Xiao Y, Luo T
Cancer Immunol Immunother. 2025; 74(3):104.
PMID: 39932560
PMC: 11813839.
DOI: 10.1007/s00262-025-03955-y.
Scholte M, Bendicksen L, Grimm S, Abu-Zahra T, Pauly B, Joore M
J Law Med Ethics. 2025; 52(4):940-949.
PMID: 39885757
PMC: 11788669.
DOI: 10.1017/jme.2024.171.
Karhana S, Samim M, Nidhi , Khan M
Arch Dermatol Res. 2025; 317(1):311.
PMID: 39873776
DOI: 10.1007/s00403-024-03785-5.
Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses.
Ofodile C, Uzochukwu I, Ezebuo F, Ejiofor I, Adebola M, Okpoli I
Viruses. 2025; 17(1).
PMID: 39861906
PMC: 11768584.
DOI: 10.3390/v17010117.
Co-selection for antibiotic resistance by environmental contaminants.
Murray L, Hayes A, Snape J, Kasprzyk-Hordern B, Gaze W, Murray A
NPJ Antimicrob Resist. 2025; 2(1):9.
PMID: 39843965
PMC: 11721650.
DOI: 10.1038/s44259-024-00026-7.
Synergistic antibacterial drug elution from UHMWPE for load-bearing implants.
Inverardi N, Serafim M, Marzouca A, Fujino K, Ferreira M, Asik M
J Mater Chem B. 2025; 13(7):2382-2399.
PMID: 39838885
PMC: 11874067.
DOI: 10.1039/d4tb02672a.
Optimization of a micro-scale air-liquid-interface model of human proximal airway epithelium for moderate throughput drug screening for SARS-CoV-2.
Sen C, Rickabaugh T, Jeyachandran A, Yuen C, Ghannam M, Durra A
Respir Res. 2025; 26(1):18.
PMID: 39819574
PMC: 11740480.
DOI: 10.1186/s12931-025-03095-y.
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer.
Matthews B, Wong-Brown M, Liu D, Yee C, Dickson K, Schneider J
Mol Ther Oncol. 2025; 32(4):200911.
PMID: 39802157
PMC: 11719850.
DOI: 10.1016/j.omton.2024.200911.
Attention-based deep learning for accurate cell image analysis.
Gao X, Zhang F, Guo X, Yao M, Wang X, Chen D
Sci Rep. 2025; 15(1):1265.
PMID: 39779905
PMC: 11711278.
DOI: 10.1038/s41598-025-85608-9.
Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure.
Park B, Kim E, Jang H, Kim Y, Ryu Y, Choi J
Theranostics. 2025; 15(3):1122-1134.
PMID: 39776792
PMC: 11700871.
DOI: 10.7150/thno.101358.
Reversal gene expression assessment for drug repurposing, a case study of glioblastoma.
Sun S, Shyr Z, McDaniel K, Fang Y, Tao D, Chen C
J Transl Med. 2025; 23(1):25.
PMID: 39773231
PMC: 11706105.
DOI: 10.1186/s12967-024-06046-1.
Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease.
Roberts C, Raabe N, Wiegand L, Kadar Shahib A, Rastegar M
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770443
PMC: 11677501.
DOI: 10.3390/ph17121601.
H1 Antihistamines-Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment.
Trybus E, Trybus W
Cancers (Basel). 2025; 16(24.
PMID: 39766152
PMC: 11674717.
DOI: 10.3390/cancers16244253.
Pan-cancer drivers of metastasis.
Lusby R, Demirdizen E, Inayatullah M, Kundu P, Maiques O, Zhang Z
Mol Cancer. 2025; 24(1):2.
PMID: 39748426
PMC: 11697158.
DOI: 10.1186/s12943-024-02182-w.
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation.
Ngernsombat C, Suriya U, Prattapong P, Verma K, Rungrotmongkol T, Soonkum T
Sci Rep. 2024; 14(1):31461.
PMID: 39733096
PMC: 11682233.
DOI: 10.1038/s41598-024-82967-7.
Identification of Anti-Tuberculosis Drugs Targeting DNA Gyrase A and Serine/Threonine Protein Kinase PknB: A Machine Learning-Assisted Drug-Repurposing Approach.
Lee D, Islam M, Natarajan S, Dudekula D, Chung H, Park J
Trop Med Infect Dis. 2024; 9(12).
PMID: 39728815
PMC: 11679129.
DOI: 10.3390/tropicalmed9120288.
Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present.
Kassab A, Gedawy E
RSC Adv. 2024; 14(54):40031-40057.
PMID: 39717807
PMC: 11664213.
DOI: 10.1039/d4ra07581a.
New or repurposed: a novel classification system for the horizon scanning of innovative medicines.
Fairbairn R, Akinbolade S, Coughlan D, Ogunbayo D, Meader N, Craig D
Int J Technol Assess Health Care. 2024; 40(1):e71.
PMID: 39651589
PMC: 11703622.
DOI: 10.1017/S0266462324004628.
